NLA Resources
Knowledge Center
Membership Resources
Join the National Lipid Association, focused on enhancing the science and practice of lipidology to promote optimal cardiometabolic health.
After making your filter selections, please scroll down to see results.
Cholesterol Guidelines and NLA Involvement
The National Lipid Association remains focused on enhancing the practice of lipid management in clinical medicine, with guideline education and participation as a critical part…
S2E2: CAC Scoring: A Discussion on the Recent NLA Scientific Statement
Dr. Alan Brown sits down with Dr. Carl Orringer and Dr. Michael Blaha to take a deeper look at the recent NLA scientific statement on…
The National Lipid Association scientific statement on coronary artery calcium (CAC) scoring to guide preventive strategies for ASCVD risk reduction
The National Lipid Association scientific statement on coronary artery calcium scoring to guide preventive strategies for ASCVD risk reduction
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
National Lipid Association Scientific Statement on the use of icosapent ethyl in statin-treated patients with elevated triglycerides and high or very-high ASCVD risk
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
Use of Lipoprotein(a) in clinical practice: A biomarker whose time has come. A scientific statement from the National Lipid Association
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association
Enhancing the value of PCSK9 monoclonal antibodies by identifying patients most likely to benefit. A consensus statement from the National Lipid Association
NLA Recommendations for Patient-Centered Management of Dyslipidemia
NLA Recommendations for Patient-Centered Management of Dyslipidemia